Related references
Note: Only part of the references are listed.Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta-analysis
Christopher J. Weatherburn et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Pharmacovigilance 2030 Invited Commentary for the January 2020 Futures Edition of Clinical Pharmacology and Therapeutics
Peter Arlett et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Measuring the impact of pharmacovigilance activities, challenging but important
Florence van Hunsel et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
'Engagement' of patients and healthcare professionals in regulatory pharmacovigilance: establishing a conceptual and methodological framework
Patrick Brown et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products
Meredith Y. Smith et al.
DRUG SAFETY (2018)
Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations
Thomas Goedecke et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
A descriptive review of additional risk minimisation measures applied to EU centrally authorised medicines 2006-2015
Annalisa Rubino et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Application of real-time global media monitoring and 'derived questions' for enhancing communication by regulatory bodies: the case of human papillomavirus vaccines
Priya Bahri et al.
BMC MEDICINE (2017)
Making sense of implementation theories, models and frameworks
Per Nilsen
IMPLEMENTATION SCIENCE (2015)
Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist
Christine Radawski et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices
Meredith Y. Smith et al.
DRUG SAFETY (2014)
Public Voices in Pharmaceutical Deliberations: Negotiating Clinical Benefit in the FDA's Avastin Hearing
Christa B. Teston et al.
JOURNAL OF MEDICAL HUMANITIES (2014)
Public Pharmacovigilance Communication A Process Calling for Evidence-Based, Objective-Driven Strategies
Priya Bahri
DRUG SAFETY (2010)
The qualitative content analysis process
Satu Elo et al.
JOURNAL OF ADVANCED NURSING (2008)
Share Paper
